BioXcel Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold BTAI, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
12
Funds holding
$729164
Total value held
Buying
7 added/new · 2 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $253001 | 179433 | +95151 | +112.90% |
| 2 | Ubs Group Ag | $222871 | 158065 | +158065 | NEW BUY |
| 3 | State Street Corp | $129886 | 92118 | — | Held |
| 4 | Northern Trust Corp | $79408 | 56318 | +20005 | +55.09% |
| 5 | Stonex Group Inc. | $29164 | 20684 | +20684 | NEW BUY |
| 6 | Wells Fargo & Company/Mn | $6115 | 4337 | +18 | +0.42% |
| 7 | Citigroup Inc | $4227 | 2998 | -9081 | -75.18% |
| 8 | Morgan Stanley | $2356 | 1671 | -8917 | -84.22% |
| 9 | Barclays Plc | $2013 | 1428 | +1428 | NEW BUY |
| 10 | Jpmorgan Chase & Co | $63 | 45 | — | Held |
| 11 | Amalgamated Financial Corp. | $59 | 2816 | +2816 | NEW BUY |
| 12 | Us Bancorp \De\ | $1 | 1 | — | Held |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.